A new dawn for gemtuzumab ozogamicin?

Affiliations

¹ Departments of Blood and Marrow Transplantation and Oncologic Sciences, H Lee Moffitt Cancer Center, University of South Florida College of Medicine, Tampa, FL 33612, USA. Electronic address: mohamed.kharfan-dabaja@moffitt.org.

Comment

Mohamed A Kharfan-Dabaja. Lancet Oncol. 2014 Aug.

. 2014 Aug;15(9):913-4.

doi: 10.1016/S1470-2045(14)70289-X. Epub 2014 Jul 6.

¹ Departments of Blood and Marrow Transplantation and Oncologic Sciences, H Lee Moffitt Cancer Center, University of South Florida College of Medicine, Tampa, FL 33612, USA. Electronic address: mohamed.kharfan-dabaja@moffitt.org.

No abstract available

Comment on

Addition of gemtuzumab ozogamicin to induction chemotherapy in adult patients with acute myeloid leukaemia: a meta-analysis of individual patient data from randomised controlled trials.
Hills RK, Castaigne S, Appelbaum FR, Delaunay J, Petersdorf S, Othus M, Estey EH, Dombret H, Chevret S, Ifrah N, Cahn JY, Récher C, Chilton L, Moorman AV, Burnett AK. Hills RK, et al. Lancet Oncol. 2014 Aug;15(9):986-96. doi: 10.1016/S1470-2045(14)70281-5. Epub 2014 Jul 6. Lancet Oncol. 2014. PMID: 25008258 Free PMC article. Review.